Premium
Prognostic and clinicopathological significance of CTTN /cortactin alterations in head and neck squamous cell carcinoma: Systematic review and meta‐analysis
Author(s) -
RamosGarcía Pablo,
GonzálezMoles Miguel Ángel,
Ayén Ángela,
GonzálezRuiz Lucía,
RuizÁvila Isabel,
GilMontoya José Antonio
Publication year - 2019
Publication title -
head and neck
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.012
H-Index - 127
eISSN - 1097-0347
pISSN - 1043-3074
DOI - 10.1002/hed.25632
Subject(s) - cortactin , medicine , oncology , basal cell , stage (stratigraphy) , head and neck squamous cell carcinoma , overall survival , head and neck , cell , pathology , head and neck cancer , cancer , biology , surgery , paleontology , genetics , cytoskeleton
Background To evaluate the prognostic significance of CTTN /cortactin alterations in head and neck squamous cell carcinoma (HNSCC). Material and methods We searched PubMed, Embase, Web of Science, and Scopus for studies published before May 2018. We conducted a meta‐analysis to quantify the impact of CTTN /cortactin alterations on clinicopathological and survival variables. Results Eighteen studies (1633 patients) met inclusion criteria. Quantitative evaluation revealed a strong association of CTTN /cortactin alterations with N+ status ( P < .001), higher T status ( P < .001), advanced clinical stage ( P < .001), high histological grade ( P = .001), and lower overall survival (OS) ( P < .001). We found heterogeneity in T status, histological grade, and OS and observed small‐study effects on N status and OS. In subgroup analyses, a significant association of CTTN amplification and cortactin overexpression with the above variables was preserved. The strongest association between CTTN /cortactin alterations and a worse outcome was observed in the subgroups of Asian patients and pharyngolaryngeal squamous cell carcinomas. Conclusions CTTN /cortactin alterations should be evaluated to predict the HNSCC prognosis.